Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 07 Jul 2021
Access to miracle drug Trikafta a 'lifeline' for cystic fibrosis patients with no other hope
7 July 2021 - A handful of cystic fibrosis patients have been thrown a lifeline with a drug company offering ...
Posted by Michael Wonder on 07 Jul 2021
Australia’s Pfizer doses are coming from Europe as US limits supply
8 July 2021 - Australia is relying on a boost in supplies from the European Union as soon as next ...
Posted by Michael Wonder on 07 Jul 2021
'This will shut us down': HIV prevention clinics brace for Gilead reimbursement cuts
7 July 2021 - An expected funding loss of at least $100 million annually will soon drain front-line clinics, threatening the ...
Posted by Michael Wonder on 07 Jul 2021
Sanders, progressives face split with centrists over plan to cut drug prices in Medicare
7 July 2021 - Those seeking bipartisan measure say empowering Medicare to negotiate for lower prices could hurt innovation. ...
Posted by Michael Wonder on 07 Jul 2021
Hyalex Orthopaedics receives FDA breakthrough device designation for novel Hyalex cartilage system
7 July 2021 - Hyalex Orthopaedics announced that the Hyalex Cartilage System has been granted breakthrough device designation from the U.S. ...
Posted by Michael Wonder on 07 Jul 2021
Valneva awarded FDA breakthrough designation for its single-shot Chikungunya vaccine candidate
7 July 2021 - This new U.S. milestone follows FDA fast track and EMA PRIME designations. ...
Posted by Michael Wonder on 07 Jul 2021
Innovative health technologies need special subsidy
7 July 2021 - Developing innovative health technologies is very important because they can extend human life by broadening the ...
Posted by Michael Wonder on 07 Jul 2021
Enzalutamide for men with hormone sensitive metastatic prostate cancer
7 July 2021 - NICE publishes final guidance on a new indication for Xtandi. ...
Posted by Michael Wonder on 07 Jul 2021
Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapy
7 July 2021 - Final guidance published after appeal. ...
Posted by Michael Wonder on 07 Jul 2021
ChemoCentryx announces filing of amendment to NDA submission and extension of the PDUFA review period for avacopan in the treatment of ANCA associated vasculitis
6 July 2021 - ChemoCentryx today announced that, following consultations with the U.S. FDA, it filed an amendment to its new ...
Posted by Michael Wonder on 06 Jul 2021
Cures for many rare diseases might already exist. Why aren’t we using them?
5 July 2021 - Scientists may have already developed cures for cystic fibrosis, muscular dystrophy, and rare cancers—they just don't realise ...
Posted by Michael Wonder on 06 Jul 2021
MHRA outlines two year delivery plan with ‘patient first’ focus
6 July 2021 - The UK’s Medicines and Healthcare products Regulatory Agency has revealed its new delivery plan, outlining its ...
Posted by Michael Wonder on 06 Jul 2021
MHRA releases guidance in collaboration with Health Canada to improve patient safety in clinical trials through improving the quality of Development Safety Update Reports
6 July 2021 - The Medicines and Healthcare products Regulatory Agency and Health Canada have published guidance to improve the safety ...
Posted by Michael Wonder on 06 Jul 2021
Costco could have saved Medicare $2.6 billion in drug spending, analysis shows
6 July 2021 - Medicare spent billions more money on generic drugs for its beneficiaries than warehouse chain Costco did ...
Posted by Michael Wonder on 06 Jul 2021
Knight Therapeutics announces Health Canada approval for Nerlynx (neratinib) to treat HER2 positive metastatic breast cancer
6 July 2021 - Knight Therapeutics announced today that Health Canada has approved Nerlynx (neratinib) in combination with capecitabine for the ...